Home Media Placements Bridging the Cultural Gap Links Contact
Awards and Honors
 
Finalist – "Entrepreneur of the Year Award"
Dr. Raza Bokhari
Ernst and Young
June 2007

"Top 25 Fast Growing Companies in South Jersey"
Lakewood Pathology Associates
Awarded by the Philadelphia Business Journal
June 2005, 2006, 2007

"Philadelphia 100"
Lakewood Pathology Associates
Sponsored by the Wharton Small Business Development Center, the Entrepreneurs’ Forum of Greater Philadelphia, and the Philadelphia Business Journal.
October 2006

"40 Under 40 Award"
Dr. Raza Bokhari
Awarded by the Philadelphia Business Journal
March 2005

"Philadelphia’s Most Innovative Executive"
Dr. Raza Bokhari
Awarded by Innovation Philadelphia
February 2005

"Best Places to Work"
Parkway Clinical Laboratories
Awarded by the Philadelphia Business Journal
October 2004

"Entrepreneur in Residence"
Dr. Raza Bokhari
Temple University Fox School of Business and Management
2001-02 academic year

FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND

Sept 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari speaks about filing with the FDA an IND Application to initiate phase 2 clinical trial to treat hospitalized COVID-19 patients. 

Click here to watch the full video

FSD Pharma says $10M in new capital is 'gratifying' as the firm makes progress in coronavirus trial

August 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari, on Proactive Investors spoke about completing US$10 million registered offering and provides progress  update on submitting IND Application to the FDA to use FSD201 to treat COVID-19 patients.

Click here to watch the full video

FSD Pharma – FDA Approval to Submit I.N.D. Application for Compound to Treat Covid-19 Patients

July 2, 2020

Dr Raza Bokhari, FSD Pharma CEO, talks about developing its ultra micro PEA Compound to treat COVID-19....

Click here to watch the video.

View Archive
 
Home | Awards and Honors | Media Placements | Bridging the Cultural Gap | Links | Contact © 2007 Dr. Raza Bokhari · All rights reserved.